Melatonin in reproduction serves as a critical biological safeguard against the damaging effects of modern environmental stressors. While the pineal gland primarily secretes this hormone to regulate circadian rhythms, reproductive tissues also produce it locally to act as a potent antioxidant. However, clinicians frequently observe that artificial light at night (ALAN) suppresses endogenous melatonin levels. Consequently, this disruption increases oxidative stress, which often compromises the quality of both sperm and eggs.

Exposure to visible light during laboratory procedures in assisted reproductive technologies (ART) generates harmful reactive oxygen species (ROS). These reactive molecules can impair the viability of gametes and significantly slow embryo development. Furthermore, research indicates that maintaining optimal melatonin concentrations remains vital for successful fertilization. Therefore, medical experts are increasingly investigating melatonin's potential to counteract these light-induced challenges in various clinical settings.

Melatonin in Reproduction: Impact on IVF Outcomes

A growing body of evidence suggests that melatonin enhances antioxidant defenses within the follicular fluid. By directly scavenging free radicals, it protects oocytes from damage and supports healthy maturation. Additionally, recent clinical trials have linked melatonin supplementation to improved blastocyst formation and higher pregnancy rates. Thus, integrating circadian management and targeted antioxidant support could optimize the success of standard fertility treatments.

Melatonin's protective role also extends to male fertility by preserving the integrity of sperm DNA. Since light exposure is often unavoidable in medical environments, melatonin offers a robust natural defense mechanism for delicate cells. Moreover, its ability to improve the uterine environment facilitates better embryo implantation for many patients. Ultimately, understanding these complex mechanisms allows specialists to refine ART protocols and significantly improve overall patient outcomes.

Frequently Asked Questions

How does artificial light at night affect fertility?

Artificial light at night suppresses the natural production of melatonin, which is a hormone essential for protecting reproductive cells from oxidative damage. This suppression often leads to lower quality eggs and sperm, potentially making conception more difficult.

What role does melatonin play in IVF success?

During IVF procedures, melatonin acts as a potent antioxidant that neutralizes reactive oxygen species (ROS) generated during laboratory embryo handling. This biological protection improves embryo quality, blastocyst formation, and successful implantation rates.

Is melatonin supplementation recommended for ART patients?

Many studies show that melatonin supplementation can improve clinical pregnancy rates and oocyte quality. However, patients must consult their fertility specialist to determine the appropriate dosage and timing based on their specific clinical profile.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Behi Shahreza P et al. Visible light, oxidative stress, and reproduction: The protective role of melatonin. Int J Gynaecol Obstet. 2026 Feb 18. doi: 10.1002/ijgo.70882. PMID: 41709096.

Ghasemnejad-Berenji H, et al. The effects of melatonin on follicular oxidative stress and ART outcomes in women with diminished ovarian reserve: a randomized controlled trial. J Ovarian Res. 2025 Jan 8;18(1):5.

Li Y, et al. Melatonin improved the outcomes of women with ART: a systematic review and meta-analysis of randomized trials. Front Reprod Health. 2025 Sep 23;7:1450231.